Merck‘s performance in 2025 started rough due to weaker-than-expected results, despite surpassing Wall Street estimates with ...
President Trump told reporters that tariffs on pharmaceuticals would start at "25% or higher," but did not say when they ...
The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback